Charlotte--H. Lundbeck will acquire drug developer Chelsea Therapeutics in a deal worth up to $658 million.

PositionStatewide: CHARLOTTE REGION

CHARLOTTE -- H. Lundbeck will acquire drug developer Chelsea Therapeutics in a deal worth up to $658 million. Chelsea, which employs 18 here, received U.S. Food and Drug Administration approval in February for its drug for dizziness and fainting connected to neurological conditions. Danish...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT